Use of α-Lactalbumin and Caseinoglycomacropeptide as Biopeptide Precursors and as Functional Additives in Milk Beverages Fermented by L. helveticus
Table 2
Number of detected biopeptide sequences (with identified bioactivity) generated from the tested protein preparations by the analyzed L. helveticus strains.
Bioactivity
Source of peptides (type of analyzed hydrolysate)
Number of bioactive peptide sequences generated by the tested L. helveticus strains
B734
DSMZ
T80
T105
Antihypertensive
CGMP
24
17
18
24
α-la
7
7
7
9
ACE inhibitory
CGMP
8
9
5
8
α-la
3
3
4
4
Antithrombotic
CGMP
3
2
2
3
α-la
—
—
—
—
Antioxidative
CGMP
3
2
3
4
α-la
1
1
1
1
Antimicrobial/antibacterial
CGMP
4
3
4
3
α-la
3
2
2
2
Immunomodulating/immuno- and cytomodulatory peptides
CGMP
2
3
2
3
α-la
2
2
2
2
Mineral binding
CGMP
—
1
1
—
α-la
—
—
—
—
Opioid agonist
CGMP
—
1
—
—
α-la
—
—
—
—
Total number of identified different biopeptide sequences
